Summary:
- The article reports on a clinical study conducted by the Department of Veterans Affairs investigating the efficacy of synthetic THC (nabilone) in treating chronic nightmares associated with post-traumatic stress disorder (PTSD).
- It highlights the scientific methodology of the trial, including the challenges of patient recruitment and the ongoing analysis of how cannabinoids interact with sleep architecture to potentially reduce trauma-related sleep disturbances.